Johnson & Johnson Mylan and Perrigo win Fda Ok to market generic Zyrtec in U.S.

Mylan Inc., the world's third-largest maker of generic drugs, and Perrigo Co. won U.S. approval to market copies of Johnson & Johnson's non-prescription allergy medicine Zyrtec. via Chicago Tribune

Comments

• Find It

• Recently Written

  • WebMD and Marketing Technology Solutions Terminate Merger Agreement
  • test post
  • AstraZeneca Enters Agreement for Authorized Generic Pulmicort Respules
  • Media Statement re: New Hampshire’s Decision to Overturn a New Hampshire U.S. District Court Ruling that Struck Down the State’s Law Banning the Commercial Use of Prescriber-Identifiable Data
  • IMS v. Ayotte - Physician Privacy Law Upheld as Constitutional by First Circuit
  • Nevada Attorney General Cortez Masto Files Suit Against Hormone Therapy Drug Manufacturers
  • Prescription Project Welcomes U.S. Appeals Court Ruling in “Data-Mining” Case
  • Garlic chemical tablet treats diabetes I and II orally
  • Widely-Used Cancer Drug Associated With Significantly Increased Risk of Blood Clots
  • Teva Receives First U.S. Approval for Generic Pulmicort Respules;Commences Commercial Launch

• Categories

  • News

• Monthly Archives

  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • December 1969

• Blogroll

  • Attorney Daily » Drug Injury News
  • Dangerous Drug Lawyer
  • Drugs.com - Pharma News
  • FDA MedWatch
  • Health Canada RSS
  • Lawyers and Settlements :: Drugs/Medical
  • Medication News

• Admin

  • Register
  • Log in
  • XHTML

Copyright © 2008 Drug Injury News